Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Cancer
|
June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Asian Journal of Neurosurgery
|
May 16, 2024
Shaping Perceptions and Inspiring Future Neurosurgeons: The Value of a Hands-On Simulated Aneurysm Clipping Workshops at a Student-Organized Neurosurgical Conference
Mohammad Ashraf, Hassan Ismahel, Devansh Shah, et al.
Cancer Cell
|
October 22, 2019
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures
Zulekha A Qadeer, David Valle-Garcia, Dan Hasson, et al.
Nature Communications
|
November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Min Pan, William C Wright, Richard H Chapple, et al.
Nature Communications
|
February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
Maged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell
|
August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
Elizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Surgical Neurology International
|
October 9, 2023
Tenth-anniversary Glasgow Neuro Society 2022 conference proceedings
Hassan Ismahel, Eilidh Elizabeth Stewart Middleton, Vivienne Eloise Evans, et al.
Pediatric Blood & Cancer
|
June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goals
Marielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
Cell Reports. Medicine
|
March 20, 2024
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Allison M Kirk, Jeremy Chase Crawford, Ching-Heng Chou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Cancer
|
June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Asian Journal of Neurosurgery
|
May 16, 2024
Shaping Perceptions and Inspiring Future Neurosurgeons: The Value of a Hands-On Simulated Aneurysm Clipping Workshops at a Student-Organized Neurosurgical Conference
Mohammad Ashraf, Hassan Ismahel, Devansh Shah, et al.
Cancer Cell
|
October 22, 2019
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures
Zulekha A Qadeer, David Valle-Garcia, Dan Hasson, et al.
Nature Communications
|
November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Min Pan, William C Wright, Richard H Chapple, et al.
Nature Communications
|
February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
Maged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell
|
August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
Elizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Surgical Neurology International
|
October 9, 2023
Tenth-anniversary Glasgow Neuro Society 2022 conference proceedings
Hassan Ismahel, Eilidh Elizabeth Stewart Middleton, Vivienne Eloise Evans, et al.
Pediatric Blood & Cancer
|
June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goals
Marielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
Cell Reports. Medicine
|
March 20, 2024
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Allison M Kirk, Jeremy Chase Crawford, Ching-Heng Chou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Page
of 14